Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1913 to 1962 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
957\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nicotinate-nucleotide pyrophosphorylase [carboxylating] (ec 2.4.2.19) (quinolinate phosphoribosyltransferase [decarboxylating]) (qaprtase) (qprtase). [source:swissprot;acc:q15274]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7895.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8202.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0388\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
structure-specific recognition protein 1 (ssrp1) (recombination signal sequence recognition protein) (t160) (chromatin-specific transcription elongation factor 80 kda subunit) (fact 80 kda subunit). [source:swissprot;acc:q08945]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4483.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4917.77\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09692\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
958\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cholinephosphate cytidylyltransferase b (ec 2.7.7.15) (phosphorylcholine transferase b) (ctp:phosphocholine cytidylyltransferase b) (ct b) (cct b) (cct-beta). [source:swissprot;acc:q9y5k3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8059.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8371.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03878\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
chromatin-specific transcription elongation factor large subunit. [source:refseq;acc:nm\_007192]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4483.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4917.77\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09692\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
959\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cholinephosphate cytidylyltransferase a (ec 2.7.7.15) (phosphorylcholine transferase a) (ctp:phosphocholine cytidylyltransferase a) (ct a) (cct a) (cct-alpha). [source:swissprot;acc:p49585]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8059.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8371.83\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03875\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sh2 domain binding protein 1; tpr-containing, sh2-binding phosphoprotein. [source:refseq;acc:nm\_014633]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4379.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4803.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09689\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
960\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase c, epsilon type (ec 2.7.1.-) (npkc-epsilon). [source:swissprot;acc:q02156]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
11773\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10733.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09688\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
reticulon protein 2 (neuroendocrine-specific protein-like 1) (nsp-like protein 1) (nspli). [source:swissprot;acc:o75298]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8206.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8524.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03873\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
961\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp response element-binding protein cre-bpa. [source:refseq;acc:nm\_004904]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8484.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8813.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03872\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
peptidyl-prolyl cis-trans isomerase b precursor (ec 5.2.1.8) (ppiase) (rotamase) (cyclophilin b) (s-cyclophilin) (scylp) (cyp-s1). [source:swissprot;acc:p23284]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11773\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10733.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09688\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
962\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
e-1 enzyme. [source:refseq;acc:nm\_021204]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8312.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8634.21\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0387\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
udp-n-acetylglucosamine--peptide n-acetylglucosaminyltransferase 110 kda subunit (ec 2.4.1.-) (o-glcnac transferase p110 subunit). [source:swissprot;acc:o15294]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
11773\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
10733.2\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.09688\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
963\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome c oxidase subunit iv isoform 1, mitochondrial precursor (ec 1.9.3.1) (cox iv-1) (cytochrome c oxidase polypeptide iv). [source:swissprot;acc:p13073]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
glycogenin-2 (ec 2.4.1.186) (gn-2) (gn2). [source:swissprot;acc:o15488]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8248.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8567.81\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0387\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
964\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome c oxidase subunit iv isoform 2, mitochondrial precursor (ec 1.9.3.1) (cox iv-2). [source:swissprot;acc:q96kj9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11773\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10733.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09688\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
renin precursor, renal (ec 3.4.23.15) (angiotensinogenase). [source:swissprot;acc:p00797]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8526.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8856.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03869\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
965\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
aspartyl protease 3 (fragment). [source:sptrembl;acc:q9uhb3]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8526.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8856.19\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03868\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase c, eta type (ec 2.7.1.-) (npkc-eta) (pkc-l). [source:swissprot;acc:p24723]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
11773.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10733.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09688\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
966\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
galectin-4 (lactose-binding lectin 4) (l-36 lactose binding protein) (l36lbp) (antigen ny-co-27). [source:swissprot;acc:p56470]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7817.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8575.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09686\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ran binding protein 3 isoform ranbp3-d; ran-binding protein-3. [source:refseq;acc:nm\_007322]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8277.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8597.67\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03868\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
967\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
napsin 1 precursor (ec 3.4.23.-) (napsin a) (napa) (ta01/ta02) (aspartyl protease 4) (asp 4) (asp4). [source:swissprot;acc:o96009]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8526.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8856.01\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03867\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein 4.1 (band 4.1) (p4.1) (epb4.1) (4.1r). [source:swissprot;acc:p11171]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7813.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8569.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09684\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
968\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cullin homolog 2 (cul-2). [source:swissprot;acc:q13617]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7882.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8187.15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03865\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
spectrin beta chain, brain 4 (spectrin, non-erythroid beta chain 4) (beta-v spectrin) (bspecv). [source:swissprot;acc:q9nrc6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7813.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8570.11\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.09684\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
969\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
band 4.1-like protein 1 (neuronal protein 4.1) (4.1n). [source:swissprot;acc:q9h4g0]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7813.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8569.95\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 2d6 (ec 1.14.14.1) (cypiid6) (p450-db1) (debrisoquine 4-hydroxylase). [source:swissprot;acc:p10635]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7935.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8242.19\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03863\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
970\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
band 4.1-like protein 3 (4.1b) (differentially expressed in adenocarcinoma of the lung protein 1) (dal-1). [source:swissprot;acc:q9y2j2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7813.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8570.07\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09684\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ca2+-dependent endoplasmic reticulum nucleoside diphosphatase; apyrase; soluble calcium-activated nucleotidase scan-1. [source:refseq;acc:nm\_138793]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8269.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8588.13\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03857\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
971\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
band 4.1-like protein 2 (generally expressed protein 4.1) (4.1g). [source:swissprot;acc:o43491]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7813.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8569.97\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09684\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ny-ren-24 antigen (fragment). [source:sptrembl;acc:q9y5a4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7462.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7750\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0385\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
972\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
45 kda calcium-binding protein precursor (cab45) (stromal cell-derived factor 4) (sdf-4). [source:swissprot;acc:q9brk5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7813.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8570.11\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09684\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
wd-repeat containing protein ciao 1. [source:swissprot;acc:o76071]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8307.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8626.88\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03849\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
973\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
galectin-9 (hom-hd-21) (ecalectin). [source:swissprot;acc:o00182]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7810.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8566.29\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09682\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nad(p)-dependent steroid dehydrogenase (ec 1.1.1.-) (h105e3 protein). [source:swissprot;acc:q15738]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8163.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8477.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03844\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
974\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 2 (ec 1.14.13.8) (pulmonary flavin-containing monooxygenase 2) (fmo 2) (dimethylaniline oxidase 2) (fmo 1b1). [source:swissprot;acc:q99518]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5365.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5884.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09682\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein-tyrosine phosphatase, non-receptor type 11 (ec 3.1.3.48) (protein-tyrosine phosphatase 2c) (ptp-2c) (ptp-1d) (sh-ptp3) (sh- ptp2) (shp-2). [source:swissprot;acc:q06124]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8375.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8696.93\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03841\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
975\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 1 (ec 1.14.13.8) (fetal hepatic flavin-containing monooxygenase 1) (fmo 1) (dimethylaniline oxidase 1). [source:swissprot;acc:q01740]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5365.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5884.43\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09679\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
metabotropic glutamate receptor 2 precursor (mglur2). [source:swissprot;acc:q14416]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7940.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8244.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0384\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
976\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 4 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 4) (fmo 4) (dimethylaniline oxidase 4). [source:swissprot;acc:p31512]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5365.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5884.32\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09675\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
metabotropic glutamate receptor 3 precursor (mglur3). [source:swissprot;acc:q14832]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7940.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8244.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0384\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
977\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
inositol polyphosphate-5-phosphatase, 145kda; hp51cn; inositol polyphosphate-5-phosphatase, 145kd. [source:refseq;acc:nm\_005541]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8204.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8519.36\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03839\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u3 small nucleolar ribonucleoprotein protein mpp10 (m phase phosphoprotein 10). [source:swissprot;acc:o00566]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4115.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4513.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09651\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
978\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
inositol polyphosphate phosphatase-like 1. [source:refseq;acc:nm\_001567]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8204.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8519.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03839\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vesicle-associated membrane protein 2 (vamp-2) (synaptobrevin 2). [source:swissprot;acc:p19065]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6654.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7296.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09649\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
979\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
reticulon protein 3 (neuroendocrine-specific protein-like 2) (nsp-like protein ii) (nsplii). [source:swissprot;acc:o95197]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8206.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8521.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03839\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vesicle-associated membrane protein 1 (vamp-1) (synaptobrevin 1). [source:swissprot;acc:p23763]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6654.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7296.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09649\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
980\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
aldehyde dehydrogenase, dimeric nadp-preferring (ec 1.2.1.5) (aldh class 3) (aldhiii). [source:swissprot;acc:p30838]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8204.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8519.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03839\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vesicule-associated membrane protein 4 (vamp-4). [source:swissprot;acc:o75379]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6654.42\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7296.51\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.09649\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
981\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cdp-diacylglycerol--inositol 3-phosphatidyltransferase (ec 2.7.8.11) (phosphatidylinositol synthase) (ptdins synthase) (pi synthase). [source:swissprot;acc:o14735]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
parafibromin. [source:refseq;acc:nm\_024529]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7404.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7688.58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03838\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/